RxDoctor Payments Data

Anik Paul, DPM

Podiatrist · East Setauket, NYNPI 1558926089

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (47.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Gotham Surgical Solutions & Devices, Inc. at 26.4% of the total. Reporting peaked in 2022 at $8,487 and has fallen 62.5% since, to $3,185 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,255in general payments, 2019–2025

Across 100 payments — averaging $152.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gotham Surgical Solutions & Devices, Inc.$4K
  • Arthrex$3K
  • Paragon 28, Inc.$2K
  • Treace Medical Concepts, Inc.$1K
  • Polaris Technology Solutions LLC$1K
  • Integra Lifesciences Corporation$735
  • plus $3K from 17 others

What the payments were for

  • Travel & lodging$4,15427%
  • Food & beverage$3,90126%
  • Education$7,20047%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,255 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$143,674
Medicare patients
197
Services billed
1,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl17$95
Cefadroxil15$63
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$38
Gabapentin14$27
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$25
Meloxicam12$11

Paid to pharmacies, not to this prescriber.

Other podiatrist in East Setauket

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →